Gênica

Gênica is a Brazilian biotechnology company specializing in the development and sale of bio-inputs for the agricultural sector. Founded in 2015 by agronomist engineer Fernando Reis, with scientific support from Professor Dr. Carlos Labate of ESALQ-USP, the company was established to create a significant impact in agribusiness through its solutions. Reis, who also founded the special fertilizers company Fast Agro, brought his entrepreneurial and agricultural expertise to the venture.

The company's business model is centered on producing biological solutions that serve as alternatives to chemical pesticides and fertilizers, catering to a growing market demand for sustainable and regenerative agriculture. Gênica develops products from microorganisms like fungi and bacteria, which help control pests and diseases, and improve nutrient absorption in plants. Its offerings are categorized into biopesticides, bio-inoculants, and biostimulants. The company serves farmers growing major crops such as soybeans, corn, and sugarcane, primarily in Brazil and Paraguay. Revenue is generated through direct sales to large agricultural players and via a network of distributors and cooperatives.

Gênica's history is marked by strategic investments that have fueled its growth. In 2017, the AgTech venture capital fund SP Ventures invested in the company, which helped establish its R&D center and testing fields. This was followed by an investment from Nitro Química in 2020, a move that expanded Gênica's sales, marketing, R&D, and manufacturing capabilities. A third investment round in 2022 was led by The Mosaic Company, a global producer of phosphates and potash. In 2024, the company secured a BRL 68 million investment round led by the Mitsubishi Group, with participation from Banco do Brasil, to further invest in R&D and market access. These financial injections have supported the company's consistent growth, reportedly doubling its revenue annually in recent years and expanding its product portfolio and operational reach.

A key component of Gênica's strategy is its REGENERA program, a comprehensive package providing customized crop management solutions and on-site training, which accounts for a significant portion of its revenue. The company has evolved from distributing third-party products to developing a proprietary portfolio, with a strong focus on combining different microorganisms for broader effectiveness. This commitment to research and development is central to its goal of becoming a leading platform for regenerative agriculture solutions in Brazil.

Keywords: bio-inputs, regenerative agriculture, agtech, biological pesticides, biostimulants, bio-inoculants, crop protection, sustainable farming, agricultural biotechnology, soil health, venture capital, crop management, Brazil agribusiness, SP Ventures, Nitro Química, The Mosaic Company, Mitsubishi Group, Fernando Reis, Carlos Labate, Marcos Petean